Arman Mosavat

ACECR

H指数:14

被引数:604

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The challenge of HTLV-1 therapeutics: lessons from anti-protease approaches

人类T细胞白血病病毒1型（HTLV-1）治疗面临的挑战：抗蛋白酶方法的启示

New Microbes and New Infections

IF5.4

2026-05-290

OAAI

Intestinal Parasitic Infections, Eosinophilia, and Th1/Th2 Immune Profiles in Haemodialysis Patients

肠道寄生虫感染、嗜酸性粒细胞增多症及Th1/Th2免疫谱在血液透析患者中的表现

PARASITE IMMUNOLOGY

IF2.1

2025-10-080

PRE

Screening of tuberculosis suspected subjects using real-time PCR, TaqMan method; Northeastern Iran

使用实时PCR和TaqMan方法对疑似结核病患者进行筛查；伊朗东北部

Journal of Infection and Public Health

IF4

2025-08-140

PREAI

Enhancing Mycobacterium tuberculosis-Ag85B immunogenicity by fusing with human Fcγ1 (Ag85B:hFcγ1)

通过与人Fcγ1融合增强结核分枝杆菌-Ag85B的免疫原性（Ag85B:hFcγ1）

Microbial Pathogenesis

IF3.5

2025-07-100

PRE

Novel insights into human T-lymphotropic virus type-1 (HTLV-1) pathogenesis-host interactions in the manifestation of HTLV-1-associated myelopathy/tropical spastic paraparesis

对人类1型T淋巴细胞病毒 (HTLV-1) 发病机制的新见解-HTLV-1-associated脊髓病/热带痉挛性呼吸暂停表现中的宿主相互作用

REVIEWS IN MEDICAL VIROLOGY

IF6.6

2024-06-270

PRE

Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region

MICROBIAL PATHOGENESIS

IF3.5

2023-08-010

PRE

Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological study

JOURNAL OF VIRUS ERADICATION

IF2

2023-06-011

OAAI

Gene Expression Study of Host and Mycobacterium tuberculosis Interactions in the Manifestation of Acute Tuberculosis

急性结核病表现中宿主与结核分枝杆菌相互作用的基因表达研究

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

IF3.3

2023-01-181

PRE

Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL)

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

IF5.5

2023-01-025

Development of a Novel HTLV-1 Protease: Human Fcγ1 Recombinant Fusion Molecule in the CHO Eukaryotic Expression System

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

IF3.3

2022-11-181

OAAI

Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein (tTax-tEnv:mFc?a) for HTLV-1 vaccine development

LIFE SCIENCES

IF5.1

2022-11-0111

PRE

Potential protective effects of chrysin against immunotoxicity induced by diazinon

SCIENTIFIC REPORTS

IF3.9

2022-09-168

OAAI

HTLV-1 oncovirus-host interactions: From entry to the manifestation of associated diseases

REVIEWS IN MEDICAL VIROLOGY

IF6.6

2021-03-1911

PREAI

High prevalence of blaCMY AmpC beta-lactamase in ESBL co-producing Escherichia coli and Klebsiella spp. clinical isolates in the northeast of Iran

产ESBL的大肠埃希菌和克雷伯菌属细菌中blaCMY AmpC β-内酰胺酶的高患病率。伊朗东北部的临床分离株

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE

IF3.2

2020-09-0128

OAAI

HTLV-1-host interactions facilitate the manifestations of cardiovascular disease

MICROBIAL PATHOGENESIS

IF3.5

2019-09-0113

PREAI

Mycobacterium tuberculosis Ag85b:hfcγ1 recombinant fusion protein as a selective receptor-dependent delivery system for antigen presentation

MICROBIAL PATHOGENESIS

IF3.5

2019-04-0111

PREAI

HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions

BMC CANCER

IF3.4

2018-12-2226

OAAI

Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE

IF3.2

2017-03-0130

PREAI

APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

IF4.3

2015-09-1559

PREAI

Evaluation of Point Mutation Detection in Mycobacterium tuberculosis with Isoniazid Resistance Using Real-Time PCR and TaqMan Probe Assay

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

IF3.3

2014-12-1215

PREAI

Arman Mosavat

个人简介

教育背景

工作经历

荣誉奖项

研究方向